Cite
HARVARD Citation
Kittle, J. et al. (2017). Cardiovascular adverse events in the drug‐development program of bupropion for smoking cessation: A systematic retrospective adjudication effort. Clinical cardiology. 40 (10), pp. 899-906. [Online].